The stock of Cosmos Health Inc (COSM) has seen a -0.71% decrease in the past week, with a -11.66% drop in the past month, and a -34.58% decrease in the past quarter. The volatility ratio for the week is 15.80%, and the volatility levels for the past 30 days are at 8.00% for COSM. The simple moving average for the last 20 days is -2.41% for COSM’s stock, with a simple moving average of -17.68% for the last 200 days.
Is It Worth Investing in Cosmos Health Inc (NASDAQ: COSM) Right Now?
Additionally, the 36-month beta value for COSM is 3.14. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for COSM is 19.72M and currently, short sellers hold a 1.84% ratio of that float. The average trading volume of COSM on November 19, 2024 was 507.46K shares.
COSM) stock’s latest price update
The stock price of Cosmos Health Inc (NASDAQ: COSM) has jumped by 11.13 compared to previous close of 0.63. Despite this, the company has seen a fall of -0.71% in its stock price over the last five trading days. accesswire.com reported 2024-11-18 that CHICAGO, IL / ACCESSWIRE / November 18, 2024 / Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has adopted a strategy to include Bitcoin and Ethereum as part of its treasury reserve assets. The adoption of this new policy follows the Company’s forward-thinking approach to investing in new technologies, including the recent acquisition of Cloudscreen, its AI-driven drug repurposing platform.
COSM Trading at -14.62% from the 50-Day Moving Average
After a stumble in the market that brought COSM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -57.58% of loss for the given period.
Volatility was left at 8.00%, however, over the last 30 days, the volatility rate increased by 15.80%, as shares sank -5.66% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -36.36% lower at present.
During the last 5 trading sessions, COSM fell by -0.71%, which changed the moving average for the period of 200-days by -34.88% in comparison to the 20-day moving average, which settled at $0.7173. In addition, Cosmos Health Inc saw -50.35% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at COSM starting from Siokas Grigorios, who purchase 60,000 shares at the price of $0.83 back on Feb 16 ’24. After this action, Siokas Grigorios now owns 1,394,597 shares of Cosmos Health Inc, valued at $49,806 using the latest closing price.
Stock Fundamentals for COSM
Current profitability levels for the company are sitting at:
- -0.36 for the present operating margin
- 0.08 for the gross margin
The net margin for Cosmos Health Inc stands at -0.47. The total capital return value is set at -0.51. Equity return is now at value -46.31, with -26.60 for asset returns.
Based on Cosmos Health Inc (COSM), the company’s capital structure generated 0.13 points at debt to capital in total, while cash flow to debt ratio is standing at -0.73. The debt to equity ratio resting at 0.14. The interest coverage ratio of the stock is -30.26.
Currently, EBITDA for the company is -17.06 million with net debt to EBITDA at -0.09. When we switch over and look at the enterprise to sales, we see a ratio of 0.32. The receivables turnover for the company is 3.21for trailing twelve months and the total asset turnover is 0.87. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.44.
Conclusion
In conclusion, Cosmos Health Inc (COSM) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
